Max Healthcare Institute Limited is one of India’s largest and most respected private healthcare providers, offering comprehensive medical care across a wide spectrum of specialties. Renowned for its state-of-the-art facilities, advanced technology, and highly skilled medical professionals, Max Healthcare is committed to delivering world-class healthcare services. Its focus on quality, innovation, and patient-centric care has made it a trusted name in the healthcare industry. As of December, 06, 2024, the Max Healthcare share price on the NSE is ₹1,098. Below are the projected Max healthcare share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Max Healthcare Institute Limited Company Overview
Founded in 2001 and headquartered in New Delhi, Max Healthcare operates a network of multi-specialty hospitals and clinics across India, with a significant presence in the National Capital Region (NCR) and North India. The company provides a wide range of medical services, including cardiology, oncology, neurology, orthopedics, organ transplantation, and critical care.
| Company type | Public |
| Traded as | BSE: 543220NSE: MAXHEALTH |
| Industry | Healthcare |
| Founded | 2001; 23 years ago |
| Headquarters | New Delhi, India |
| Area served | India |
| Key people | Abhay Soi (Chairman & MD) |
| Revenue | ₹7,215 crore(US$860 million) (FY24) |
| Operating income | ₹1,907 crore(US$230 million) (FY24) |
| Net income | ₹1,278 crore(US$150 million) (FY24) |
| Number of employees | 15,000 (2023) |
| Website | www.maxhealthcare.in |
Max Healthcare Share Price Target from 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | ₹1250 | ₹650 | ₹1140 |
| 2025 | ₹1600 | ₹830 | ₹1450 |
| 2026 | ₹1970 | ₹1050 | ₹1700 |
| 2027 | ₹2200 | ₹1350 | ₹2020 |
| 2028 | ₹2620 | ₹1780 | ₹2450 |
| 2029 | ₹3050 | ₹2070 | ₹2650 |
| 2030 | ₹3480 | ₹2290 | ₹3100 |
| 2035 | ₹5800 | ₹2850 | ₹5250 |
| 2040 | ₹8350 | ₹4500 | ₹7950 |
Technical Analysis for Max Healthcare Institute
Max Healthcare Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | ₹1450 | ₹1600 |
Max Healthcare has established itself as a prominent player in India’s premium healthcare sector, focusing on urban and metro cities. With the increasing demand for high-quality medical facilities and Max’s investment in expanding its reach and upgrading its infrastructure, the share price is projected to reach ₹1450 for the first target and ₹1600 for the second target by 2025. The company’s consistent revenue growth and strong patient base make these targets achievable.
Read More:- Fortis Healthcare Share Price Target 2025, 2030, 2035, 2040
Max Healthcare Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | ₹1780 | ₹1970 |
By 2026, Max Healthcare is likely to benefit from further developments in the private healthcare sector, along with its ongoing efforts to enhance its service offerings and increase operational efficiency. With its focus on high-margin treatments and advanced healthcare technologies, the share price is estimated to touch ₹1780 for the first target and ₹1970 for the second target. The company’s strategic partnerships and focus on specialized care will further boost investor confidence.
Max Healthcare Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | ₹2100 | ₹2200 |
By 2027, Max Healthcare is expected to grow further, driven by increased healthcare spending and its leadership in quality care. The share price is anticipated to hit ₹2100 for the first target and ₹2200 for the second target.
Max Healthcare Share Price Target 2028
| Year | 1st Target | 2nd Target |
| 2028 | ₹2500 | ₹2620 |
In 2028, as the healthcare sector matures and demand for private healthcare continues to rise, the share price is forecasted to reach ₹2500 for the first target and ₹2620 for the second target.
Max Healthcare Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | ₹2870 | ₹3050 |
By 2029, with expansions and innovations in healthcare services, Max Healthcare’s share price is expected to climb to ₹2870 for the first target and ₹3050 for the second target.
Max Healthcare Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | ₹3270 | ₹3480 |
In 2030, driven by robust growth and operational excellence, the share price is estimated to reach ₹3270 for the first target and ₹3480 for the second target.
Max Healthcare Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | ₹4700 | ₹5800 |
Looking at the long-term growth trajectory, Max Healthcare’s share price is expected to rise to ₹4700 for the first target and ₹5800 for the second target by 2035, fueled by consistent expansion and profitability.
Read More:- Apollo Share Price Target 2025, 2030, 2035, 2040
Max Healthcare Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | ₹7500 | ₹8350 |
By 2040, with Max Healthcare becoming a dominant player in the Indian healthcare landscape, the share price is projected to touch ₹7500 for the first target and ₹8350 for the second target, reflecting its long-term potential and growth.
Max Healthcare Institute Ltd. Fundamentals
| Metric | Value |
| Market Cap | ₹1,06,482Cr |
| P/E Ratio (TTM) | 100.58 |
| P/B Ratio | 12.10 |
| Industry P/E | 73.50 |
| Debt to Equity | 0.20 |
| ROE (Return on Equity) | 12.03% |
| EPS (TTM) | 10.89 |
| Dividend Yield | 0.14% |
| 52 Week High | ₹1118 |
| 52 Low High | ₹630 |
| Book Value | 90.51 |
| Face Value | 10 |
Max Healthcare Institute Ltd. Financial Results
| All in ₹Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
| Sales | 2,508 | 3,937 | 4,563 | 5,406 | 6,008 |
| Expenses | 2,101 | 2,986 | 3,322 | 3,914 | 4,403 |
| Operating Profit | 407 | 951 | 1,241 | 1,492 | 1,605 |
| OPM % | 16% | 24% | 27% | 28% | 27% |
| Other Income | -122 | 110 | 139 | 178 | 167 |
| Interest | 179 | 101 | 84 | 60 | 89 |
| Depreciation | 174 | 221 | 232 | 245 | 292 |
| Profit before tax | -69 | 739 | 1,064 | 1,365 | 1,390 |
| Tax % | 67% | 18% | -4% | 23% | |
| Net Profit | -138 | 605 | 1,104 | 1,058 | 1,059 |
| EPS in Rs | -1.42 | 6.24 | 11.37 | 10.88 | 10.90 |
| Dividend Payout % | 0% | 0% | 9% | 14% |
Max Healthcare Institute Ltd. Balance Sheet
| All in ₹Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
| Equity Capital | 966 | 970 | 971 | 972 | 972 |
| Reserves | 4,673 | 5,313 | 6,439 | 7,436 | 7,827 |
| Borrowings | 1,101 | 913 | 689 | 1,299 | 1,768 |
| Other Liabilities | 1,803 | 1,993 | 2,003 | 2,293 | 2,560 |
| Total Liabilities | 8,543 | 9,189 | 10,102 | 12,000 | 13,127 |
| Fixed Assets | 6,536 | 7,018 | 7,039 | 8,784 | 9,506 |
| CWIP | 27 | 151 | 252 | 553 | 588 |
| Investments | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 1,980 | 2,020 | 2,810 | 2,661 | 3,030 |
| Total Assets | 8,543 | 9,189 | 10,102 | 12,000 | 13,127 |
Max Healthcare Institute Ltd. Shareholding Pattern
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 70.46% | 50.64% | 23.77% | 23.75% | 23.74% |
| FIIs | 17.96% | 14.59% | 51.96% | 57.33% | 57.29% |
| DIIs | 4.88% | 17.57% | 19.36% | 14.96% | 15.14% |
| Public | 6.70% | 17.20% | 4.92% | 3.97% | 3.84% |
| No. of Shareholders | 45,491 | 1,20,079 | 1,04,656 | 1,27,009 | 1,37,856 |
Max Healthcare Institute Ltd. Dividend History
| Announcement Date | Ex-Dividend Date | Dividend Type | Dividend |
| 22 May, 2024 | 23 Aug, 2024 | Final | 1.50 |
| 16 May, 2023 | 08 Sep, 2023 | Final | 1.00 |
Max Healthcare Institute Ltd. Peer comparison
| Sector: Healthcare | |||||
| Name | P/E | Mar CapRs.Cr. | Div Yld% | NP QtrRs.Cr. | ROCE% |
| Max Healthcare | 99.95 | 105806.88 | 0.14 | 281.81 | 16.00 |
| Apollo Hospitals | 88.48 | 104688.16 | 0.22 | 395.70 | 15.11 |
| Fortis Health. | 77.21 | 53111.32 | 0.14 | 193.08 | 10.34 |
| Global Health | 64.57 | 31516.06 | 0.00 | 130.81 | 19.32 |
| Poly Medicure | 96.40 | 28430.92 | 0.10 | 87.45 | 23.62 |
| Narayana Hrudaya | 34.67 | 26985.78 | 0.31 | 198.80 | 26.54 |
| Dr Lal Pathlabs | 63.69 | 25571.89 | 0.79 | 130.80 | 25.17 |
FAQ
Q.1. What is the price target for Max Healthcare Institute in 2025?
Ans: The projected share price targets for 2025 are ₹1450 (1st target) and ₹1600 (2nd target), reflecting steady growth driven by the company’s focus on premium healthcare services and increasing patient demand.
Q.2.What is the share price target for Max Healthcare Institute in 2026?
Ans: For 2026, the price could increase to ₹1780 (1st target) and ₹1970 (2nd target). This is because Max Healthcare is expanding and helping more patients.
Q.3. What are the expected share price targets for Max Healthcare Institute Ltd. in 2027?
Ans: In 2027, the share price might reach ₹2100 (1st target) and ₹2200 (2nd target), as the company continues to improve its services and facilities.
Q.4. What is the forecasted share price for Max Healthcare Institute Ltd. in 2028?
Ans: By 2028, the price could rise to ₹2500 (1st target) and ₹2620 (2nd target), thanks to its growing popularity and trust among patients.
Q.5. What are the share price targets for Max Healthcare Institute in 2029?
Ans: In 2029, the share price might go up to ₹2870 (1st target) and ₹3050 (2nd target), as the company gets bigger and better.
Q.6. What is the projected share price for Max Healthcare Institute Ltd. in 2030?
Ans: By 2030, the share price is likely to reach ₹3270 (1st target) and ₹3480 (2nd target). Max Healthcare will continue to grow and serve more people.
Q.7. What are the long-term share price targets for Max Healthcare Institute Ltd. in 2035?
Ans: In 2035, the share price could be ₹4700 (1st target) and ₹5800 (2nd target), as the company becomes a leader in the healthcare industry.
Q.8. What is the share price forecast for Max Healthcare Institute Ltd. in 2040?
Ans: By 2040, the share price might reach ₹7500 (1st target) and ₹8350 (2nd target). This shows how Max Healthcare is expected to keep growing and helping many more patients.
Q.9. Who is the CEO of Max Healthcare Institute?
Ans: Max Healthcare Institute Limited is led by Abhay Soi, who serves as the Chairman and Managing Director (CMD). He is a first-generation entrepreneur credited with transforming the company and significantly expanding its hospital network.
Q.10. What are the NSE and BSE codes for Max Healthcare Institute Services?
Ans: Max Healthcare Institute Ltd. is listed on the stock exchanges with the following codes: NSE Code: MAXHEALTH, BSE Code: 543220.
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.